Medical Devices Ordinance
(MedDO)


Open article in different language:  DE  |  FR  |  IT
Art. 24 Involvement of a designated body

1 When a des­ig­nated body is in­volved, all the in­form­a­tion ne­ces­sary for the con­form­ity as­sess­ment must be made avail­able to it.

2 Man­u­fac­tur­ers must not sim­ul­tan­eously ap­ply to more than one des­ig­nated body in Switzer­land or a con­tract­ing state to carry out a con­form­ity as­sess­ment pro­ced­ure for the same product.

3 Any nat­ur­al or leg­al per­son who ap­plies to a des­ig­nated body must in­form that body wheth­er an ap­plic­a­tion to a dif­fer­ent des­ig­nated body in Switzer­land or a con­tract­ing state has been with­drawn be­fore a de­cision was is­sued or re­jec­ted by a dif­fer­ent des­ig­nated body in Switzer­land or a con­tract­ing state.

4 If a man­u­fac­turer with­draws its ap­plic­a­tion to have a con­form­ity as­sess­ment pro­ced­ure car­ried out be­fore the des­ig­nated body has is­sued its de­cision on the as­sess­ment, the des­ig­nated body in ques­tion shall no­ti­fy Swiss­med­ic and the oth­er des­ig­nated bod­ies.

5 ...62

6 Where a man­u­fac­turer vol­un­tar­ily changes the des­ig­nated body, it must com­ply with the re­quire­ments of Art­icle 58 EU-MDR63.

62 Re­pealed by An­nex 5 No 1 of the O of 4 May 2022 on In Vitro Dia­gnost­ic Med­ic­al Devices, with ef­fect from 26 May 2022 (AS 2022 291).

63 See the foot­note to Art. 4 para. 1 let. f.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden